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Regarding “InterGard silver bifurcated graft:
Features and results of a multicenter study”
Ricco1 recently published an article containing a meta-
analysis but did not describe the techniques of the analysis. The
absence of methodology stimulates the following questions:
What were the inclusion/exclusion criteria for selection of the
comparator studies? As presented, it is impossible to reproduce
the meta-analysis or, more importantly, discern the effect of
various biases.2,3 How robust was the conclusion from the
meta-analysis when possible confounding factors were consid-
ered? Various types of bias are inherent within any meta-
analysis. It is a basic necessity of all meta-analyses to perform
sensitivity analyses to demonstrate the robustness of results.4,5
Did the studies in the meta-analysis report graft infection in
terms of odds ratios, or did the authors extrapolate these data
from reported percentages and counts? Translation of percent-
age and count data directly into an odds ratio without account-
ing for differences in follow-up duration between individual
studies would introduce statistical bias. Moreover, the authors
fail to state whether individual study data were weighted to
derive the combined odds ratio and did not describe the calcu-
lation method used: either fixed-effect or random-effect mod-
eling.3 Do the wide confidence intervals for the odds ratio of the
author’s study (0.21 with a 95% confidence interval of 0.01-4.4)
really reflect a reproducible outcome? The dashed vertical line in
their Forrest plot (fig 6)1 corresponds to no effect (odds ratio
1.0). If the confidence interval of individual studies includes 1,
then it is debatable whether any difference in the effect estimate
of one treatment vs another is significant at conventional levels
(P  .05). Finally, did the authors consider the homogeneity vs
heterogeneity of individual studies used? The poolability of
individual study data in the meta-analysis was not discussed,
although the data in the Forrest plot (fig 6)1 suggest that
individual study data were homogeneous. Consequently, we
believe that the authors should have commented on the appli-
cability of their conclusion toward patient populations with
characteristics (eg, comorbidities and risk factors) that are dif-
ferent from the patient populations considered.5
This postmarketing study has a commendable data return,
considering its study type and follow-up duration, with just 2.8%
patients lost to follow-up over a mean of 55 months.1 Complete
disposition of all patients from all centers through each study
period would have been useful. Kaplan-Meier curves with a 3-year
follow-up are presented despite a reported mean follow-up longer
than 4.5 years. The low attrition rate and follow-up duration
suggest that data are available to show outcomes well beyond the
selected follow-up of 3 years. A rationale for limiting the survival
data to 3 years would be appropriate.
There are remarkably few English-language publications on
the use of silver-coated bifurcated vascular grafts.1,6 Answers to the
above methodologic and reporting issues would allow readers to
better judge the validity of the stated conclusions.
Stephen A. O’Connor, PhD, Hon FRCP
4 The Green
Bedfordshire, United Kingdom
Peter Andrew, MMedSci, PhD
ATLAS Medical Research Inc.
Saint Lazare, Canada
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Reply
We appreciate the letter from O’Connor and Andrew con-
cerning our article, but we want to clarify the following points
concerning the methodology of the study and the meta-analysis
presented in the article.
The purpose of our prospective multicenter study was to
evaluate the safety, patency, and infection rate of a bifurcated aortic
polyester graft coated with collagen and silver acetate. As pointed
out by O’Connor and Andrew, our study had only 2.8% of patients
lost to follow-up over a mean of 55 months. This result was
achieved by adequate monitoring of all centers. In addition, uni-
formity and completeness in complication reporting was verified
during on-site monitoring visits by comparing complications in
charts with those in the case-report form. As usual, the Kaplan-
Meier curves were used to report patient survival and primary and
secondary patency up to 3 years. As pointed out by O’Connor and
Andrew, follow-up was longer for some patients, and technically
any survival plot can be extended right through to the longest
follow-up time. However, this extension is not good statistical
practice, because for any such plot the eye is drawn to the right (ie,
where the plot finishes), where there is least information and
greatest uncertainty. Much of the right-hand part of the plot can
Fig. Funnel plots with graft infection log odds ratios from indi-
vidual studies on the horizontal axis and standard error reflecting
the study size on the vertical axis. The name funnel plot is based on
the fact that the precision in the estimation of graft infection will
increase as the sample size of component studies increases. Effect
estimates from small studies will therefore scatter more widely at
the bottom of the graph, with the spread narrowing among larger
studies. In the absence of bias, as shown here with data from our
studies, the plot will resemble a symmetrical inverted funnel.
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depict just a few patients. We agree with Pocock et al,1 who
recommend that survival plots be halted once the proportion of
patients free of an event, but still in follow-up, becomes small.
What constitutes “small” is open to debate and depends on the
context. We considered that after 3 years, the 85 patients still at risk
(29%) made the data less representative and that some sensible
cutoff was needed.
Concerning the meta-analysis, we agree with O’Connor and
Andrew that the methodology used was not detailed in our article,
in part because it was a very small part of the overall work and
concerned graft infection rate according to the type of bypass: ie,
aortofemoral (1.3%; 95% confidence interval [CI], 0% to 3.2%) vs
aortoiliac (0%). Even though this was not the primary goal of the
study, we did a meta-analysis to better understand these results and
enhance the value of our study. We did a careful literature search to
find studies that compared aortofemoral and aortoiliac bypasses
with detailed analysis concerning graft infection rates in both
operations. Simple criteria were used to match the studies to be
combined, including study design and methodology, patient pop-
ulations, quality of follow-up, treatment strategies, and primary
outcomes. There was no evidence of heterogeneity [Q statistic
value, 5.2; df (Q)  10; P  .87] or publication bias among these
studies, as shown by the use of the funnel plots (Fig). Data
extraction and assessment of the quality of the available data were
performed in a standard form. Finally, statistical analysis was per-
formed to enable interpretation of the pooled effect with odds
ratios by using the fixed-effects model with 95% CIs. As shown in
the table, the result generated for the estimated pooled odds ratios
was 0.287; (95% CI, 0.18 to 0.42), indicating that graft infection
was probably lower in aortoiliac grafts vs aortofemoral grafts, a
tendency observed in other studies (Table). We recognize, how-
ever, that summarizing all the information contained in a selected
set of trials into a single odds ratio may greatly oversimplify a more
complex issue.2 We hope that the above methodologic and report-
ing issues will allow the reader to appreciate the validity of our
study, which demonstrates the safety and excellent primary patency
of the InterGard silver graft.
Jean-Baptiste Ricco, MD, PhD
University of Poitiers
Poitiers, France
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Table. Details of the meta-analysis comparing graft infection in aortofemoral and aortoiliac bypasses with calculation of
the odds ratio including 95% confidence interval [lower and upper limit] and relative weight for each study3
Model Study
Statistics for each study
Weight (fixed);
relative weightOdds ratio Lower limit Upper limit Z-value p-value
Szilagyi 0.434 0.126 1.436 1.329 0.184 16.52
Goldstone 0.393 0.081 1.906 1.160 0.246 10.05
Jamieson 0.284 0.076 1.058 1.876 0.061 14.48
Liekweg 0.119 0.023 0.610 2.552 0.011 9.37
Yashar 0.536 0.141 2.033 0.917 0.359 14.10
Lorentzen 0.038 0.002 0.611 2.306 0.021 3.22
O’Hara 0.305 0.101 0.920 2.108 0.035 20.56
Szilagyi 0.331 0.020 5.487 0.771 0.440 3.18
Edwards 0.118 0.007 2.128 1.448 0.148 3.00
Al Khaffaf 0.148 0.008 2.902 1.529 0.208 2.83
Our series 0.215 0.010 4.558 0.986 0.324 2.69
Fixed 0.287 0.176 0.424 4.879 0.000
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